Tanguamos, Baby Boy .
HRN: 26-44-25 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/30/2024
01/06/2025
IV
44mg
Q24h
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes